Ornithine may serve as a biomarker for IR in PKU, as it has been described that it can activate membrane depolarization in pancreatic islet β-cells, leading to increased cytosolic Ca2+ levels and the subsequent stimulation of insulin secretion [38]. This evidence concerns the gene INS and phenylketonuria.